These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11479827)

  • 21. The use of opiate antagonists for recurrent self-injurious behavior.
    Buzan RD; Thomas M; Dubovsky SL; Treadway J
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):437-44. PubMed ID: 8555746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychodynamic treatments of self-injury.
    Levy KN; Yeomans FE; Diamond D
    J Clin Psychol; 2007 Nov; 63(11):1105-20. PubMed ID: 17932991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adolescents with borderline disorders--self and other destructive behavior in inpatient psychotherapy].
    Streeck-Fischer A
    Prax Kinderpsychol Kinderpsychiatr; 2000 Sep; 49(7):497-510. PubMed ID: 11072732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone treatment of self-injurious thoughts and behaviors.
    Sonne S; Rubey R; Brady K; Malcolm R; Morris T
    J Nerv Ment Dis; 1996 Mar; 184(3):192-5. PubMed ID: 8600226
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenomenology of self-injury among inpatient women with borderline personality disorder.
    Shearer SL
    J Nerv Ment Dis; 1994 Sep; 182(9):524-6. PubMed ID: 8083682
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of dissociative symptoms with nalmefene in patients with borderline personality disorder and complex posttraumatic stress disorder].
    Enning F; Schmahl C
    Nervenarzt; 2022 May; 93(5):503-505. PubMed ID: 34860275
    [No Abstract]   [Full Text] [Related]  

  • 28. On treatment mechanisms--what can we learn from the COMBINE study?
    Bergmark A
    Addiction; 2008 May; 103(5):703-5. PubMed ID: 18190670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Childhood trauma in the etiology of borderline personality disorder].
    Kuritárné IS
    Psychiatr Hung; 2005; 20(4):256-70. PubMed ID: 16462003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligodipsia and dissociative experiences in borderline personality disorder.
    Hoeschel K; Guba K; Kleindienst N; Limberger MF; Schmahl C; Bohus M
    Acta Psychiatr Scand; 2008 May; 117(5):390-3. PubMed ID: 18331578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.
    Kellner M
    Pharmacopsychiatry; 2007 Jan; 40(1):41. PubMed ID: 17327963
    [No Abstract]   [Full Text] [Related]  

  • 34. Naltrexone as a treatment of self-injurious behavior--a case report.
    Griengl H; Sendera A; Dantendorfer K
    Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder.
    Glover H
    Isr J Psychiatry Relat Sci; 1993; 30(4):255-63. PubMed ID: 8163362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid antagonists in the treatment of impulse-control disorders.
    Kim SW
    J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.
    Johansson BA; Berglund M; Lindgren A
    Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Promising therapy of borderline personality disorder].
    Andersson G
    Lakartidningen; 2006 Oct 18-24; 103(42):3188-90. PubMed ID: 17111989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.